Juan M. Palacios-Segura

Marbella, AN, Spain

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 19 publications

Potential clinical factors associated with secukinumab dose selection in the treatment of hidradenitis suppurativa: a cohort study of 132 patients.

Potential clinical factors associated with secukinumab dose selection in the treatment of hidradenitis suppurativa: a cohort study of 132 patients.

Journal: The Journal of dermatological treatment

Published: June 27, 2025

Safety and Efficacy of Bimekizumab in Patients With Moderate-to-Severe Hidradenitis Suppurativa: A Multicenter Retrospective Cohort Study.

Safety and Efficacy of Bimekizumab in Patients With Moderate-to-Severe Hidradenitis Suppurativa: A Multicenter Retrospective Cohort Study.

Journal: Actas dermo-sifiliograficas

Published: July 30, 2024

[Translated article] Nadolol for Infantile Hemangiomas Previously Treated with Propranolol.

[Translated article] Nadolol for Infantile Hemangiomas Previously Treated with Propranolol.

Journal: Actas dermo-sifiliograficas

Published: March 12, 2023

Intramuscular ertapenem for the treatment of severe cases hidradenitis suppurativa.

Intramuscular ertapenem for the treatment of severe cases hidradenitis suppurativa.

Journal: The Journal of dermatological treatment

Published: February 13, 2023

Short-Term Effectiveness, Safety, and Potential Predictors of Response of Secukinumab in Patients with Severe Hidradenitis Suppurativa Refractory to Biologic Therapy: A Multicenter Observational Retrospective Study.

Short-Term Effectiveness, Safety, and Potential Predictors of Response of Secukinumab in Patients with Severe Hidradenitis Suppurativa Refractory to Biologic Therapy: A Multicenter Observational Retrospective Study.

Journal: Dermatology and therapy

Published: January 26, 2023

Reply to: "Comment on 'Interruption of oral clindamycin plus rifampicin therapy in patients with hidradenitis suppurativa: An observational study to assess prevalence and causes'".

Reply to: "Comment on 'Interruption of oral clindamycin plus rifampicin therapy in patients with hidradenitis suppurativa: An observational study to assess prevalence and causes'".

Journal: Journal of the American Academy of Dermatology

Published: March 04, 2019

Ultrasound as a diagnostic and management tool in hidradenitis suppurativa patients: a multicentre study.

Ultrasound as a diagnostic and management tool in hidradenitis suppurativa patients: a multicentre study.

Journal: Journal of the European Academy of Dermatology and Venereology : JEADV

Published: October 26, 2018

Topical treatment with oleocanthal extract in reducing inflammatory reactions after photodynamic therapy: a prospective quasi-experimental pilot study.

Topical treatment with oleocanthal extract in reducing inflammatory reactions after photodynamic therapy: a prospective quasi-experimental pilot study.

Journal: Complementary therapies in medicine

Published: September 01, 2018

Long-term efficacy of photodynamic therapy with methyl aminolevulinate in treating Bowen's disease in clinical practice: A retrospective cohort study (2006-2017).

Long-term efficacy of photodynamic therapy with methyl aminolevulinate in treating Bowen's disease in clinical practice: A retrospective cohort study (2006-2017).

Journal: Photodermatology, photoimmunology & photomedicine

Published: July 14, 2018

Interruption of oral clindamycin plus rifampicin therapy in patients with hidradenitis suppurativa: An observational study to assess prevalence and causes.

Interruption of oral clindamycin plus rifampicin therapy in patients with hidradenitis suppurativa: An observational study to assess prevalence and causes.

Journal: Journal of the American Academy of Dermatology

Published: June 29, 2018

Human Papilloma Virus and the Risk of Squamous Cell Carcinoma Arising in Hidradenitis Suppurativa.

Human Papilloma Virus and the Risk of Squamous Cell Carcinoma Arising in Hidradenitis Suppurativa.

Journal: Actas dermo-sifiliograficas

Published: April 03, 2017

Panniculitis Due to Atypical Mycobacteria After Mesotherapy.

Panniculitis Due to Atypical Mycobacteria After Mesotherapy.

Journal: Actas dermo-sifiliograficas

Published: February 20, 2017

Showing 1-12 of 19

Last Updated: 09/26/2026